CYP19A1 and breast cancer: However, tamoxifen has been shown to have a favorable effect on the lipid profile,80, 81, 82 and in a population-based study of 17,922 patients with breast cancer, aromatase inhibitors were associated with increased risks for heart failure and cardiovascular mortality compared with the use of tamoxifen.83